Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Cancer Res. 2017 Jul 28;77(18):4835–4845. doi: 10.1158/0008-5472.CAN-17-0143

Figure 4.

Figure 4.

Prognostic impact of NSDΊ methylation and correlation with SETD2 mutation. A, Association between NSDΊ methylation and SETD2 somatic mutations in TCGA dataset shows high rate of NSDΊ methylation in tumors with SETD2 mutations. B, Kaplan-Meier curves for overall survival according to NSDΊ methylation in TCGA cohort (450 K). C, Kaplan-Meier curves for recurrence-free survival according to NSDΊ methylation in Pitié-Salpêtrière cohort. D, Progression-free survival according to NSDΊ methylation in patients with ccRCC treated with sunitinib (Beuselinck cohort).